Description

CJC-1295 with DAC — 10 mg

Investigational Peptide for Growth Hormone Support

CJC-1295 with DAC is an investigational peptide designed to mimic aspects of growth hormone–releasing hormone (GHRH) activity. The DAC (Drug Affinity Complex) component is designed to extend the peptide’s activity in the body, allowing for more sustained stimulation of growth hormone release.

It has been investigated for its effects on growth hormone and related metabolic pathways and is sometimes discussed in wellness and body-composition settings. However, clinical evidence for its use in general wellness, muscle development, fat loss, or anti-aging remains limited, and it is not FDA-approved for these purposes.

If considered as part of a clinician-supervised wellness program, potential benefits, limitations, and risks should be carefully reviewed with a qualified healthcare professional following an individualized clinical evaluation.

Treatment eligibility is determined individually following an appropriate clinical evaluation.